Isolation of mouse mesenchymal stem cells with normal ploidy from bone marrows by reducing oxidative stress in combination with extracellular matrix
© Fan et al; licensee BioMed Central Ltd. 2011
Received: 24 January 2011
Accepted: 6 July 2011
Published: 6 July 2011
Isolation of mouse MSCs (mMSCs) with normal ploidy from bone marrow remains challenging. mMSCs isolated under 20% O2 are frequently contaminated by overgrown hematopoietic cells, and could also be especially vulnerable to oxidative damage, resulting in chromosomal instability. Culture under low oxygen or extracellular matrix (ECM) improves proliferation of MSCs in several species. We tested the hypothesis that culture under low oxygen in combination with ECM prepared from mouse embryonic fibroblast (MEF-ECM) could be used to purify proliferative mMSCs, and to reduce oxidative damage and maintain their chromosomal stability.
Optimization of culture conditions under 20% O2 resulted in immortalization of mMSCs, showing extensive chromosome abnormalities, consistent with previous studies. In contrast, culture under low oxygen (2% O2) improved proliferation of mMSCs and reduced oxidative damage, such that mMSCs were purified simply by plating at low density under 2% O2. MEF-ECM reduced oxidative damage and enhanced proliferation of mMSCs. However, these isolated mMSCs still exhibited high frequency of chromosome abnormalities, suggesting that low oxygen or in combination with MEF-ECM was insufficient to fully protect mMSCs from oxidative damage. Notably, antioxidants (alpha -phenyl-t-butyl nitrone (PBN) and N-acetylcysteine (NAC)) further reduced DNA damage and chromosomal abnormalities, and increased proliferation of mMSCs. mMSCs isolated by the combination method were successfully used to generate induced pluripotent stem (iPS) cells by ectopic expression of Oct4, Sox2, Klf4 and c-Myc.
We have developed a technique that allows to reduce the number of karyotypic abnormalities for isolation of primary mMSCs and for limited culture period by combination of low oxygen, MEF-ECM, antioxidants and low density plating strategy. The effectiveness of the new combination method is demonstrated by successful generation of iPS cells from the isolated mMSCs. However, a culture system for mMSCs still is needed to prevent all the anomalies, especially after a long-term culture period.
MSCs first described by Friedenstein  show great potency of differentiation into osteoblasts, chondrocytes, adipocytes, and other lineages , and have gained widespread use in various research fields, and created great promise for cell therapy. While bone marrow derived MSCs (also named marrow stromal cells) have been successfully isolated by plastic adherence from many species including human, bovine and rat [2–5], isolation of normal ploidy mouse MSCs (mMSCs) from bone marrow remains to be big challenging. First, mMSCs isolated by the classical method of plastic adherence are frequently contaminated by overgrown hematopoietic cells . mMSCs could be purified at early passage by immunodepletion of hemaetopoetic cells, but the immunodepleted cells exhibited poor proliferation [7, 8]. Other methods for purifying mMSCs require long-term culture under various conditions [9–12]. However, those isolated mMSCs were actually immortalized stromal cell lines similar to hundreds of murine marrow stromal cell lines established during the past few decades . This was further proved by several studies showing that mMSCs could transform spontaneously upon in vitro culture [13–16].
Another characteristic of mMSCs is their high chromosomal instability [13, 15–19]. Bone marrow mesenchymal stem cells in vivo adapt to low oxygen tension in the bone microenvironment ; culture under normal oxygen atmosphere (20% O2) may exert excess oxidative damage to mMSCs. Furthermore, mouse cells are more sensitive than human cells to oxygen , and immortalization of MEF under 20% O2 has been associated with increased oxidative DNA damage . Thus, mMSCs under standard culture conditions (20% O2) could be especially vulnerable to oxidative damage, leading to chromosome instability and finally immortalization and transformation. Indeed, low oxygen has been consistently shown to improve proliferation of MSCs in several species including human, rat, and porcine [23–26], and also primary mMSCs [27–29].
MSCs seeded onto extracellular matrix (ECM) show enhanced proliferation. ECM or components of ECM such as laminin and collagen could increase expansion ability of human MSCs [30–32]. Hyaluronan and fibrin also improve proliferation of mouse adipose-derived MSCs and bone marrow MSCs, respectively [33, 34]. Nevertheless, intact ECM created from PYS-2 cells influences proliferation of human MSCs more than its major components, laminin and type IV collagen. ECM generated from MEF (MEF-ECM) is widely used as a substrate for derivation and maintenance of human embryonic stem cell (ES) lines . It would be interesting to test whether MEF-ECM affects proliferation and ploidy of mMSCs.
Initially, we attempted to isolate mMSCs under classical 20% O2 condition and obtained only immortalized mMSCs lines with frequent chromosome abnormalities and even with tumorigenic potentials. Following extensive experimentation, we developed an improved method to purify mMSCs with normal ploidy by seeding marrow cells directly onto MEF-ECM at 5 × 104 cells/cm2 under 2% O2, with addition of antioxidants in the primary culture.
Culture under 20% O2 leads to immortalization of mMSCs
Low (2%) O2 improves purification of mMSCs
Low density plating strategy was proved to benefit purification of mMSCs [9, 39, 40]. Primary mMSCs obtained under 2% O2 were replated at 1,000/cm2 and incubated for 3 to 4 days. At this stage, most of the cultured cells (designated as CmMSCs, see below) appeared as fibroblasts-like cells, similar to IDmMSCs cultured under 2% O2. Moreover their epitopes were also similar to those of IDmMSCs, negative for hematopoietic marker CD45 and CD11b, and endothelial marker CD31 and Flk-1, but positive for Sca-1 and CD44 (Figure 3B). Under appropriate conditions, CmMSCs at passage one were readily induced to differentiate into adipocytes, osteocytes and chondrocytes (Figure 3C). Together, culture of mMSCs under 2% O2 could successfully deplete most of contaminated hematopoietic cells, such that relatively pure mMSCs could be obtained at very early passage.
MEF-ECM enhances proliferation of mMSCs
We further tested whether effects of MEF-ECM on expansion of mMSCs were associated with decreased oxidative damage. First, we measured levels of cellular reactive oxygen species (ROS) in mMSCs. ROS generated during normal oxidative metabolism may cause damage to DNA and contribute to genomic instability . Cellular DCFDA fluorescence, indicative of relative ROS levels, was found significantly reduced in EmMSCs compared to CmMSCs (Figure 4C). We then evaluated the DNA double-strand breaks using flow cytometry analysis of γ-H2AX, which is routinely used to measure DNA damage caused by endogenous oxidants and other factors such as magnetic resonance imaging (MRI) exposure [42–44]. EmMSCs showed greatly decreased γ-H2AX intensity compared to CmMSCs (Figure 4D), suggesting reduced oxidative damage to mMSCs cultured on MEF-ECM. Reduced DNA damage was further revealed by micronucleus assay. While CmMSCs exhibited higher frequency of spontaneous micronucleus formation, EmMSCs showed greatly reduced MN (Figure 4E). Thus, mMSCs expanded on MEF-ECM showed reduced oxidative damage.
Karyotypes of mMSCs cultured under 2% O2
Number of chromosomes
Total number of metaphases
Normal karyotype (%)
PEmMSCs P0 (low density)
Antioxidants increase proliferation and chromosome stability of mMSCs
To test whether artificial induction of oxidative stress increases chromosomal damages and abnormalities, we treated mMSCs for 24 hours with H2O2 at the concentrations that did not cause immediate cell death and found that H2O2 reduced cell proliferation (Figure 5C) and induced chromosomal damages as shown by increased rates of micronuclei (Figure 5D), despite that the concentration and treatment time of H2O2 used in this experiment did not cause appreciable abnormal karyotypes of mMSCs (Figure 5E).
We further evaluated effects of antioxidants on proliferation and ploidy of mMSCs following longer-term culture. mMSCs cultured without antioxidants showed a phase of slow growth at passage 3 and most of cells exhibited flat enlarged morphology like senescence, followed by gradual renewed growth possibly due to outgrowth of some actively growing colonies. In contrast, cells cultured with antioxidants continued proliferation. Notably, PEmMSCs (mMSCs on MEF-ECM in the presence of PBN and NAC) proliferated to passage 8 without obvious growth arrest (about 30 population doublings, Figure 5F). mMSCs at passage 8 proliferated actively and showed typical MSCs morphology as fibroblast-like cells. Yet, CmMSCs, EmMSCs or PCmMSCs (mMSCs cultured on plastic in the presence of PBN and NAC) at passage 8 showed nearly absent normal karyotype, whereas PEmMSCs at passage 8 still showed normal ploidy in 28% (14/50) of spreads analyzed (Table 1). These results indicate that combination of antioxidants and MEF-ECM might reduce oxidative damage to mMSCs to some extent and improve viability and chromosome stability of mMSCs for longer-term.
Isolation of primary mMSCs with normal ploidy by seeding bone marrows cells directly onto MEF-ECM
Generation of induced pluripotent stem cells from mMSCs
MSCs are routinely cultured under 20% O2 in DMEM or α-MEM, supplemented with 10-20% fetal bovine serum. Isolation and long-term culture of mouse MSCs under these classical culture conditions has been found problematic, compared to that of other species . Consistent with previous studies , our data show that normal ploidy mMSCs are rarely achieved despite of enormous efforts to optimize culture conditions under 20% O2. However, mMSCs can be purified simply by culture under 2% O2, mainly attributable to significantly improved proliferation of mMSCs and reduced oxidative damage. Also, passaging by harvesting only easily detached cells without pipetting [9, 48] and seeding at a relatively low density of 1000 cells/cm2 improves purification and proliferation of mMSCs, such that a purer population of mMSCs could be obtained only 9 days after initiation of culture.
ECM prepared from MEF further expands mMSCs and reduces oxidative damage. This might be explained by more undifferentiated state and higher antioxidant defence capacity of mMSCs expanded by MEF-ECM. Stress defence of stem cells is usually superior to that of differentiated cells , and ECM could maintain higher differentiation potential of multipotent MSCs than that of bare plastic [30, 31, 33, 50]. We did not quantitatively compare the differentiation potential of mMSCs expanded on plastic and MEF-ECM, but the smaller size may imply a more undifferentiated state of mMSCs expanded by MEF-ECM. Thus, combination of low oxygen and MEF-ECM might provide an effective strategy for obtaining relatively pure mMSCs at more undifferentiated state and with less oxidative damage at early passage.
However, mMSCs cultured on either plastic or MEF-ECM show high frequency of chromosome abnormalities. Further, chromosome abnormalities are found just upon primary in vitro culture of bone marrow cells. Consistently, several groups have already reported chromosome abnormalities in bone marrow derived mMSCs cultured under 20% O2[13, 15–19]. Recently, adipose tissue-derived mMSCs under long-term culture also exhibit chromosomal abnormalities , suggesting mouse species-specific sensitivity to oxidative damage and chromosomal instability . Chromosome abnormalities found in early passage mMSCs under 2% O2 suggest that low oxygen alone or in combination with MEF-ECM is insufficient to protect mMSCs from oxidative damage and chromosome instability. But increased rates of normal chromosomes found in EmMSCs than in CmMSCs suggest a possible role of MEF-ECM in reducing chromosome instability of mMSCs.
Antioxidants might confer mMSCs additional antioxidant defence capacity. A combination of two antioxidants (PBN and NAC) significantly reduces spontaneous MN and increases normal karyotype of primary mMSCs, in association with increased proliferation of mMSCs. Particularly, mMSCs could be expanded continuously on MEF-ECM without noticeable growth arrest for at least 8 passages (about 30 population doublings, Figure 5F). One-third of PEmMSCs still exhibit normal ploidy by passage 8, in contrast to nearly absent normal ploidy found in CmMSCs, EmMSCs and PCmMSCs, suggesting that antioxidants in combination with MEF-ECM improve proliferation and chromosomal stability of mMSCs.
Together, a method to isolate mMSCs with normal ploidy is developed by combination of low oxygen, antioxidants and MEF-ECM. Consistent with another study , directly seeding marrow cells on MEF-ECM leads to contamination of a small fraction of hemaetopoietic cells. This problem can be partly resolved by lowering seeding density from 2 × 105 cells/cm2 to 5 × 104 cells/cm2. Seeding at low density has been adopted to obtain pure primary mMSCs [39, 40]. As a result, a purified population of mMSCs with normal ploidy can be obtained only 6 days after initiation of primary culture.
The quality of mMSCs isolated by the new combination method was further tested by their potential to generate iPS cells. iPS cells have been induced from various types of mouse cells, including fibroblasts , adipose tissue-derived cells and neural stem cells , and hepatocytes and gastric epithelial cells . Poor quality of mMSCs may hinder their reprogramming process of iPS cells. With limited experiments, we successfully generated iPS cells from mMSCs isolated by our new method with at least comparable efficiency to TTFs, one of the most commonly used donor cells for iPS induction . We found that iPS cell like colonies formed earlier from mMSCs than from TTFs, suggesting that mMSCs could be prone to reprogramming. However, more studies are needed to determine whether the resulted iPS cells from mMSCs show more complete reprogramming and higher quality than from other cell types, but successful generation of iPS cells from mMSCs validated the effectiveness of our new method. On the other hand, accessibility in clinics of somatic cells for iPS induction is a consideration. Our method can be adaptable to human MSCs derived from bone marrow aspirations, since both low oxygen and ECM are shown to benefit for growth of human MSCs [24, 30]. hMSCs cultured by the new method could be appropriate somatic cells for induction of iPS cells for potential therapeutic uses.
We have developed a method for isolation of relatively pure primary mMSCs with normal ploidy by combination of low oxygen, MEF-ECM, antioxidants and low density plating strategy. mMSCs isolated by this method were successfully used to generate iPS cells. These normal ploidy mMSCs could also be useful for numerous other studies in the mesenchymal stem cell field. Our data also suggest that conditions for long-term culture of mMSCs should be developed to maintain normal ploidy mMSCs for future uses.
Preparation of MEF-ECM-coated wells
MEF was isolated from 13.5 dpc embryos of C57BL/6 × DBA/2 hybrid background and maintained as described . For preparation of MEF-ECM-coated wells, confluent passage one MEF cultures in 6 well plates were allowed to continue for another day. The cultured cells were treated with 20 mM NH3 and 0.5% Triton X-100 for 5 min at room temperature, the lysis buffer was removed, and the plates were placed without cover for 20 min to allow the ECM adhere firmly to the substrata of the wells. The substratum was washed five times with Hanks' balanced salt solution (HBSS; Invitrogen) and stored at 4°C for subsequent uses.
Isolation and expansion of mMSCs
Young B6D2F1 mice (3-5 weeks old) were sacrificed by cervical dislocation using protocol approved by the Institutional Animal Committee. Whole bone marrow was harvested by flushing femurs and tibiae as described . The marrow cells were plated into 6-well cell culture plate at a density of 2 × 105 cells/cm2 in 2.5 ml DMEM containing 20% fetal bovine serum (Hyclone) and 1% penicillin-streptomycin antibiotics (Invitrogen). In some experiments, a combination of antioxidants (800 μM alpha -phenyl-t-butyl nitrone (PBN) and 5 mM N-acetylcysteine (NAC)) were added in the medium. In others, bone marrow cells were seeded directly onto MEF-ECM-coated wells. Cells were cultured at an atmosphere of 2% O2 (2% O2, 93% N2, 5% CO2) at 37°C. Non-adherent cells were removed after 24 hours by washing twice with phosphate-buffered saline (PBS), and fresh medium added. At day 5-6, adherent cells were treated with 0.25% trypsin/0.02% EDTA (Invitrogen) for 3 min at 37°C. The cells lifted within 3 min were collected and replated at 1000 cells/cm2 onto uncoated 6-well plates or plates coated with MEF-ECM. The medium was replaced every 2-3 days until cells reached 90% confluence. Subsequent passaging was carried out using the same conditions.
For initial experiments to optimize culture conditions under 20% O2, the marrow cells were plated at a higher density of 2 × 106 cells/cm2, and subcultures were performed at a split ratio of 1:3 when cells reached 90% confluence.
For immunodepletion experiments, retrieved primary mMSCs were stained with PE-conjugated anti-CD45 and anti-Ter119 antibodies (Miltenyi Biotec), and then stained with anti-PE magnetic microbeads (Miltenyi Biotec) and immunodepeleted according to the manufacturer's instruction. Cells negative for CD45 and Ter119 were seeded onto 6-well plates at 10, 000 cells/cm2.
In vitro Differentiation of mMSCs
To induce osteogenic differentiation, 70-80% confluent mMSCs were incubated in osteogenic medium (DMEM supplemented with 20% FBS, 20 mM β-glycerol phosphate, 1 nM dexamethasone and 0.5 μM ascorbate 2-phosphate) for one week with medium changed once, based on a method with slight modification . The cells were fixed with 3.7% paraformaldehyde and stained with Alizarin Red (pH 4.1).
To induce adipogenic differentiation, 70-80% confluent mMSCs were incubated in adipogenic medium (DMEM supplemented with 20% FBS, 0.5 μM hydrocortisone, 0.5 mM isobutylmethylxanthine (IBMX) and 60 μM indomethacin , for one week and the medium was changed once. The cells were fixed in 3.7% paraformaldehyde and stained with 0.5% Oil Red in propylene glycol.
Chondrogenic differentiation was performed in 70-80% confluent monolayer or in a pellet  formed by centrifugation of 2 × 105 mMSCs. The chondrogenic medium consisted of high-glucose DMEM supplemented with 500 ng/ml bone morphogenetic protein-2 (BMP-2; Peprotech), 10 ng/ml transforming growth factor β3 (TGF-β3; Peprotech), 10-7 M dexamethasone, 50 μg/ml ascorbate-2-phosphate, 40 μg/ml proline, 100 μg/ml pyruvate, 1 × insulin-transferrin-selenium and 1 × lenolenic acid-bovine serum albumin (LA-BSA) (Sigma). The monolayers or pellets were incubated in this medium for 1-2 weeks with medium change twice a week. The monolayers were fixed and stained with Alcian blue. The pellets were embedded in tissue-freezing medium (Leica), sectioned into 8-μm slices, fixed with cold acetone and stained with Alcian blue.
Immunostaining and FACS analysis
For flow cytometry analysis of mMSCs epitope, following PE conjugated antibodies were used: CD31, CD34, Flk-1, Sca-1, CD44 (eBioscience), CD45, CD11b (Miltenyi Biotec). Cells were divided into aliquots (5 × 104 each), stained with PE-conjugated antibodies at final concentration of 2 μg/ml at room temperature for 30 min, washed with PBS and analyzed by flow cytometry. For flow cytometry analysis of γ-H2AX, cells were fixed with 3.7% paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked in 3% normal goat serum (Sigma) in PBS. After incubation with 2 μg/ml anti-γ-H2AX antibody (Upstate, 05-636) at 4 °C overnight, the cells were washed and stained with Alexa 488-conjugated goat anti-mouse IgG (1:100 v/v, Molecular Probes) for 1 hour, and washed and analyzed as above. Immunostaining of pluipotency-associated markers was performed with following primary antibodies: Oct-4 (sc5279, Santa Cruz, CA), Nanog (Abcam, ab10626) and SSEA1 (DSHB, MC-480), and secondary antibodies: Texas red conjugated anti-mouse IgG (Vector, TI-2000, CA) or Alexa fluor 488 goat anti-mouse IgM (Molecular Probes). Immunofluorescence was observed and imaged using a Leica microscope equipped with epi-fluorescence and appropriate filters.
Intracellular reactive oxygen species (ROS) was determined by flow cytometry using 5-b-chloromethyl-2'7'-dichlorodihydrofluorescin diacetate (CM-H2DCFDA; Molecular Probes) [49, 57]. mMSCs were harvested by trypsin-EDTA and incubated in serum-free medium containing 10 μM CM-H2DCFDA for 30 min at 37°C. Then the cells were washed, resuspended, and analyzed by flow cytometry. The median fluorescence intensity was used to estimate intracellular ROS levels.
Micronucleus (MN) assay
Micronucleus assay was performed as described with slight modification . Cultured mMSCs at 50-80% confluence were incubated with 4.5 μg/ml cytochalasin-B (Sigma) for 24 hours and harvested. After a brief hypotonic treatment in 0.075 M KCl, cells were fixed in methanol/acetic acid (5:1), stained with 5 μg/ml Hoechst 33342 (Molecular Probes) in PBS and mounted for immunofluorescence microscopy. Frequency of micronucleus was assessed on 1000 binucleated cells for each culture in three independent experiments.
Karyotype analysis and telomere fluorescence in situ hybridization (FISH)
mMSCs at 50-80% confluence were incubated with 0.1 μg/ml colcemid (Sigma) for 5 h. The cells were incubated in hypotonic solution (0.075 M KCl), fixed in methanol/acetic acid (3:1) and spread onto slides. Cell spreads were stained with 5 μg/ml Hoechst 33342 (Molecular Probes) in PBS, examined by immunofluorescence microscope, and number of chromosomes were counted. FISH with FITC-labelled telomere-specific (CCCTAA)3 peptide nucleic acid (PNA) probe (Applied Biosystems, Framingham, MA, USA) was performed as described .
2 × 106 mMSCs were subcutaneously injected into 4 weeks old BALB/c nude mice. The animals were monitored for tumor formation for two months. Formed tumors were excised, fixed in formalin, paraffin embedded, sectioned, and stained with hematoxylin and eosin.
Generation of iPS cells
iPS cells were induced by transduction of four Yamanaka's factors according to the protocol of Okita et al.  with slight modifications. Briefly, pMXs-based retroviral vectors (pMXs-Sox2, Klf4, Oct4, c-Myc) were introduced into Plat-E cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. The viral supernatant were collected, filtered (0.45 μm pore size) and supplemented with 8 μg/ml polybrene before use. The day before infection, primary mMSCs and tail-tip fibroblasts (TTFs) were plated at 5 × 104 cells/well into 6-well plates coated with MEF-ECM or gelatin. The mMSCs and TTFs were infected with virus/polybrene-containing supernatant twice within forty eight hours. Three days after infection, the cells were replated in ES medium (knock-out DMEM supplemented with 20% FBS, 1000 U/ml LIF, 0.1 mM β-mercaptoethanol, 1 mM L-glutamine and 0.1 mM nonessential amino acids). The cells were passaged at day 5 onto MEF feeders and the medium was changed every day. ES-like colonies were picked by day 10 to 13, and passaged onto MEF feeders.
Alkaline phosphatase staining
Alkaline phosphatase assay was performed using the Vector Blue Aalkaline Phosphatase Substrate Kit (Vector Laboratories, DAKO, Carpinteria, CA) according to manufacturer's instruction.
The data were analyzed by Student's t-test. Results are expressed as mean ± SD. A value of p < 0.05 was considered significant by comparison. All experiments were performed at least three times.
List of abbreviations used
mouse mesenchymal stem cells
alpha -phenyl-t-butyl nitrone
mMSCs on control plastic
mMSCs on ECM
mMSCs on control plastic in the presence of PBN and NAC
mMSCs on ECM in the presence of PBN and NAC. TTFs: tail-tip fibroblasts
- iPS cells:
induced pluripotent stem cells.
We thank Lingyan Zhu for providing flow cytometry analysis and Yifei Liu and Junjiu Huang for helpful discussion of the manuscript. We are indebted to Dr. Huayu Qi for his assistance in hydrogen peroxide experiment. This study was supported by the Science and Technology Division of Guangdong Province.
- Friedenstein AJ, Gorskaja JF, Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976, 4: 267-74.PubMed
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-7. 10.1126/science.284.5411.143.View ArticlePubMed
- Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997, 276: 71-4. 10.1126/science.276.5309.71.View ArticlePubMed
- Javazon EH, Colter DC, Schwarz EJ, Prockop DJ: Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells. 2001, 19: 219-25. 10.1634/stemcells.19-3-219.View ArticlePubMed
- Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T: Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell Tissue Res. 2005, 319: 243-53. 10.1007/s00441-004-1012-5.View ArticlePubMed
- Phinney DG, Kopen G, Isaacson RL, Prockop DJ: Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem. 1999, 72: 570-85. 10.1002/(SICI)1097-4644(19990315)72:4<570::AID-JCB12>3.0.CO;2-W.View ArticlePubMed
- Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG: Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem. 2003, 89: 1235-49. 10.1002/jcb.10594.View ArticlePubMed
- Phinney DG: Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol Biol. 2008, 449: 171-86. 10.1007/978-1-60327-169-1_12.PubMed
- Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004, 103: 1662-8. 10.1182/blood-2003-09-3070.View ArticlePubMed
- Meirelles Lda S, Nardi NB: Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003, 123: 702-11. 10.1046/j.1365-2141.2003.04669.x.View ArticlePubMed
- Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, Mao N: Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells. 2003, 21: 527-35. 10.1634/stemcells.21-5-527.View ArticlePubMed
- Tropel P, Noel D, Platet N, Legrand P, Benabid AL, Berger F: Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004, 295: 395-406. 10.1016/j.yexcr.2003.12.030.View ArticlePubMed
- Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006, 24: 1095-103. 10.1634/stemcells.2005-0403.View ArticlePubMed
- Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM: Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007, 25: 371-9. 10.1634/stemcells.2005-0620.View ArticlePubMed
- Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, Stamp G, Bonnet D, Janes SM: Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells. 2007, 25: 1586-94. 10.1634/stemcells.2006-0762.View ArticlePubMed
- Zhou YF, Bosch-Marce M, Okuyama H, Krishnamachary B, Kimura H, Zhang L, Huso DL, Semenza GL: Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res. 2006, 66: 10849-54. 10.1158/0008-5472.CAN-06-2146.View ArticlePubMed
- Grinchuk TM, Ivantsov KM, Alekseenko LL, Kozhukharova IV, Zaichik AM, Petrov NS, Mikhailov VM, Popov BV: [Characterization of cultured murine mesenchymal stem cell line expressing GFP]. Tsitologiia. 2008, 50: 1030-5.PubMed
- Inoue K, Noda S, Ogonuki N, Miki H, Inoue S, Katayama K, Mekada K, Miyoshi H, Ogura A: Differential developmental ability of embryos cloned from tissue-specific stem cells. Stem Cells. 2007, 25: 1279-85. 10.1634/stemcells.2006-0747.View ArticlePubMed
- Josse C, Schoemans R, Niessen NA, Delgaudine M, Hellin AC, Herens C, Delvenne P, Bours V: Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2010, 19: 1167-73. 10.1089/scd.2009.0264.View ArticlePubMed
- Chow DC, Wenning LA, Miller WM, Papoutsakis ET: Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J. 2001, 81: 685-96. 10.1016/S0006-3495(01)75733-5.PubMed CentralView ArticlePubMed
- Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J: Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003, 5: 741-7. 10.1038/ncb1024.View ArticlePubMed
- Busuttil RA, Rubio M, Dolle ME, Campisi J, Vijg J: Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell. 2003, 2: 287-94. 10.1046/j.1474-9728.2003.00066.x.View ArticlePubMed
- Moussavi-Harami F, Duwayri Y, Martin JA, Moussavi-Harami F, Buckwalter JA: Oxygen effects on senescence in chondrocytes and mesenchymal stem cells: consequences for tissue engineering. Iowa Orthop J. 2004, 24: 15-20.PubMed CentralPubMed
- Grayson WL, Zhao F, Bunnell B, Ma T: Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun. 2007, 358: 948-53. 10.1016/j.bbrc.2007.05.054.View ArticlePubMed
- Lennon DP, Edmison JM, Caplan AI: Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol. 2001, 187: 345-55. 10.1002/jcp.1081.View ArticlePubMed
- Bosch P, Pratt SL, Stice SL: Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod. 2006, 74: 46-57.View ArticlePubMed
- Schooley JC, Kullgren B, Fletcher BL: Growth of murine bone marrow adherent stromal cells in culture without hydrocortisone in a low oxygen environment. Int J Cell Cloning. 1985, 3: 2-9. 10.1002/stem.5530030103.View ArticlePubMed
- Gupta V, Rajaraman S, Costanzi JJ: Effect of oxygen on the clonal growth of adherent cells (CFU-F) from different compartments of mouse bone marrow. Exp Hematol. 1987, 15: 1153-7.PubMed
- Ren H, Cao Y, Zhao Q, Li J, Zhou C, Liao L, Jia M, Zhao Q, Cai H, Han ZC: Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun. 2006, 347: 12-21. 10.1016/j.bbrc.2006.05.169.View ArticlePubMed
- Matsubara T, Tsutsumi S, Pan H, Hiraoka H, Oda R, Nishimura M, Kawaguchi H, Nakamura K, Kato Y: A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun. 2004, 313: 503-8. 10.1016/j.bbrc.2003.11.143.View ArticlePubMed
- Mauney JR, Volloch V, Kaplan DL: Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials. 2005, 26: 6167-75. 10.1016/j.biomaterials.2005.03.024.View ArticlePubMed
- Mauney JR, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan DL: Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A. 2006, 79: 464-75.View ArticlePubMed
- Chen PY, Huang LL, Hsieh HJ: Hyaluronan preserves the proliferation and differentiation potentials of long-term cultured murine adipose-derived stromal cells. Biochem Biophys Res Commun. 2007, 360: 1-6. 10.1016/j.bbrc.2007.04.211.View ArticlePubMed
- Rivkin R, Ben-Ari A, Kassis I, Zangi L, Gaberman E, Levdansky L, Marx G, Gorodetsky R: High-yield isolation, expansion, and differentiation of murine bone marrow-derived mesenchymal stem cells using fibrin microbeads (FMB). Cloning Stem Cells. 2007, 9: 157-75. 10.1089/clo.2006.0039.View ArticlePubMed
- Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R: Human embryonic stem cells derived without feeder cells. Lancet. 2005, 365: 1636-41. 10.1016/S0140-6736(05)66473-2.View ArticlePubMed
- Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002, 418: 41-9. 10.1038/nature00870.View ArticlePubMed
- Ebert R, Ulmer M, Zeck S, Meissner-Weigl J, Schneider D, Stopper H, Schupp N, Kassem M, Jakob F: Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells. 2006, 24: 1226-35. 10.1634/stemcells.2005-0117.View ArticlePubMed
- Buravkova LB, Anokhina EB: Effect of hypoxia on stromal precursors from rat bone marrow at the early stage of culturing. Bull Exp Biol Med. 2007, 143: 411-3. 10.1007/s10517-007-0143-6.View ArticlePubMed
- Wang QR, Wolf NS: Dissecting the hematopoietic microenvironment. VIII. Clonal isolation and identification of cell types in murine CFU-F colonies by limiting dilution. Exp Hematol. 1990, 18: 355-9.PubMed
- Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M: Murine mesenchymal stem cells isolated by low density primary culture system. Dev Growth Differ. 2006, 48: 361-70. 10.1111/j.1440-169X.2006.00874.x.View ArticlePubMed
- Jackson AL, Loeb LA: The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001, 477: 7-21.View ArticlePubMed
- Schwenzer NF, Bantleon R, Maurer B, Kehlbach R, Schraml C, Claussen CD, Rodegerdts E: Detection of DNA double-strand breaks using gammaH2AX after MRI exposure at 3 Tesla: an in vitro study. J Magn Reson Imaging. 2007, 26: 1308-14. 10.1002/jmri.21138.View ArticlePubMed
- Zhao H, Tanaka T, Halicka HD, Traganos F, Zarebski M, Dobrucki J, Darzynkiewicz Z: Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes. Cytometry A. 2007, 71: 905-14.View ArticlePubMed
- Tanaka T, Kajstura M, Halicka HD, Traganos F, Darzynkiewicz Z: Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif. 2007, 40: 1-13.PubMed
- Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN: Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA. 1995, 92: 4337-41. 10.1073/pnas.92.10.4337.PubMed CentralView ArticlePubMed
- Ksiazek K, Mikula-Pietrasik J, Jorres A, Witowski J: Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells. Free Radic Biol Med. 2008, 45: 460-7. 10.1016/j.freeradbiomed.2008.04.032.View ArticlePubMed
- Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989, 6: 593-7. 10.1016/0891-5849(89)90066-X.View ArticlePubMed
- Nadri S, Soleimani M, Hosseni RH, Massumi M, Atashi A, Izadpanah R: An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int J Dev Biol. 2007, 51: 723-9. 10.1387/ijdb.072352ns.View ArticlePubMed
- Saretzki G, Armstrong L, Leake A, Lako M, von Zglinicki T: Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells. 2004, 22: 962-71. 10.1634/stemcells.22-6-962.View ArticlePubMed
- Zhao Y, Lin H, Zhang J, Chen B, Sun W, Wang X, Zhao W, Xiao Z, Dai J: Crosslinked three-dimensional demineralized bone matrix for the adipose-derived stromal cell proliferation and differentiation. Tissue Eng Part A. 2009, 15: 13-21. 10.1089/ten.tea.2008.0039.View ArticlePubMed
- Qin Y, Ji H, Wu Y, Liu H: Chromosomal instability of murine adipose tissue-derived mesenchymal stem cells in long-term culture and development of cloned embryos. Cloning Stem Cells. 2009, 11: 445-52. 10.1089/clo.2009.0006.View ArticlePubMed
- Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126: 663-76. 10.1016/j.cell.2006.07.024.View ArticlePubMed
- Tat PA, Sumer H, Jones KL, Upton K, Verma PJ: The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant. 2010, 19: 525-36. 10.3727/096368910X491374.View ArticlePubMed
- Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S: Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008, 321: 699-702. 10.1126/science.1154884.View ArticlePubMed
- Nagy A, Gertsenstein M, Vintersten K, Behinger R: Preparing mouse embryo fibroblasts. Manipulating the Mouse Embryo. 2003, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 371-373. 3
- Liu L, DiGirolamo CM, Navarro PA, Blasco MA, Keefe DL: Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res. 2004, 294: 1-8. 10.1016/j.yexcr.2003.10.031.View ArticlePubMed
- Liu L, Trimarchi JR, Smith PJ, Keefe DL: Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell. 2002, 1: 40-6. 10.1046/j.1474-9728.2002.00004.x.View ArticlePubMed
- Fenech M: In vitro micronucleus technique to predict chemosensitivity. Methods Mol Med. 2005, 111: 3-32.PubMed
- Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature. 2007, 448: 313-7. 10.1038/nature05934.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.